UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015757
Receipt number R000017783
Scientific Title Research on a Quantitative Assessment of Radiation-Induced Skin Symptoms
Date of disclosure of the study information 2014/11/26
Last modified on 2020/06/12 18:09:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on a Quantitative Assessment of Radiation-Induced Skin Symptoms

Acronym

Quantitative Assessment of Radiation-Induced Skin Symptoms

Scientific Title

Research on a Quantitative Assessment of Radiation-Induced Skin Symptoms

Scientific Title:Acronym

Quantitative Assessment of Radiation-Induced Skin Symptoms

Region

Japan


Condition

Condition

Breast cancer

Classification by specialty

Radiology Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purposes of this study are to assess multilateral changes of radiation-induced skin symptoms quantitatively and find out relations with the exposure dose. The study also uses a qualitative grading evaluation and QOL questionnaires and examines the effectiveness of the assessments.

Basic objectives2

Others

Basic objectives -Others

To assess successive changes in skin symptoms.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Period: Before radiation therapy, during radiation therapy (once in a week), after radiation therapy (2 and 6 weeks, 3 and 6 months, and 1 year post treatment)

<Assessment by devices>
Erythema & melanin index

Key secondary outcomes

Period: Before radiation therapy, during radiation therapy (once in a week), after radiation therapy (2 and 6 weeks, 3 and 6 months, and 1 year post treatment)

<Assessment by devices>
1) Transepidermal water loss
2) Capacitance (stratum corneum-epidermal water)
3) Skin temperature

<Visual assessment>
NCI-CTC (ver.4.0 Japanese version JCOG)

<Self-completed questionnaires>
Skindex 29 (QOL regarding skin symptoms)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

69 years-old >=

Gender

Female

Key inclusion criteria

1) Patients with breast cancer who are treated with whole-breast radiation after breast-conserving surgery.
2) PS is from 0 to 1.
3) Patients who agreed to participate in this study.

Key exclusion criteria

1) Patients who should be treated with a boost radiation.
2) Patients who are treated with pharmacotherapy except for hormone therapy during radiation therapy.
3) Patients who are unable to respond to self-completed questionnaires.
4) Physician decides it is inappropriate for the patient to participate in this study.
5) Patients who are going to stop radiation therapy for a long time (e.g., at the end of and the beginning of a year).

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Sekine

Organization

The Jikei University School of Medicine

Division name

Department of Radiology

Zip code

201-8601

Address

4-11-1 Izumi-Honcyo, Komae, Tokyo 201-8601, Japan

TEL

03-3480-1151

Email

h-sekine@jikei.ac.jp


Public contact

Name of contact person

1st name Nozawa
Middle name
Last name Keiko

Organization

National Cancer Center Hospital

Division name

Appearance Support Center

Zip code

104-0045

Address

5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045

TEL

03-3547-5201(3015)

Homepage URL


Email

knozawa@ncc.go.jp


Sponsor or person

Institute

National Cancer Center Hospital, Appearance Support Center

Institute

Department

Personal name



Funding Source

Organization

Health and Labor Sciences Research Grants 2014

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor

The Jikei University
Mie University
Tohoku University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cancer Center Institutional Review Board

Address

5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045

Tel

03-3542-2511

Email

NCC_IRBoffice@ml.res.ncc.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立がん研究センター中央病院(東京都)、東京慈恵会医科大学病院(東京都)
三重大学病院(三重県)、東北大学病院(宮城県)


Other administrative information

Date of disclosure of the study information

2014 Year 11 Month 26 Day


Related information

URL releasing protocol

Breast Cancer On line: 03 May 2020 https://doi.org/10.1007/s12282-020-01082-3

Publication of results

Published


Result

URL related to results and publications

Breast Cancer On line: 03 May 2020 https://doi.org/10.1007/s12282-020-01082-3

Number of participants that the trial has enrolled

43

Results

Finally, 40 patients were followed until 1 year after irradiation.
The order of symptom manifestation for the qualitative evaluation was skin erythema, dryness, and pigmentation. Quantitative measurements revealed the effects of irradiation earlier than did qualitative indices. Although the grades of skin erythema and pigmentation were correlated with the quantitative measurements, no significant correlation was observed between the skin dryness grade and skin barrier function.

Results date posted

2020 Year 06 Month 12 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Female patients with newly diagnosed unilateral breast cancer were enrolled. All patients underwent BCS followed by whole-breast irradiation (WBI).
The exclusion criteria were an age >70 years; previous history of contralateral beast cancer; receipt of boost irradiation after WBI; receipt of chemotherapy before, simultaneously with, or after the completion of irradiation; connective tissue disease; and expected long-term interruption of radiation therapy.

Participant flow

Participants who received BCS were irradiated with tangential opposed fields with a dose of 50 Gy in 25 fractions. Qualitative and quantitative evaluation of radiation dermatitis were performed weekly during irradiation and periodically until 1 year of irradiation.

Adverse events

This study confirms whether the qualitative evaluation of radiation dermatitis, which is a side effect of radiotherapy, is reproducible between and within evaluators by comparing it with quantitative evaluation. The subject is a radiotherapy patient after breast-conserving surgery in which the method of radiotherapy is uniform. There were no adverse effects that interrupted the irradiation with this treatment.

Outcome measures

Symptoms (erythema, pigmentation, and skin dryness) and biophysical parameters (erythema, pigmentation, barrier function, and skin temperature) of radiation dermatitis were measured weekly during radiation therapy and periodically until 1 year after irradiation.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 11 Month 04 Day

Date of IRB

2014 Year 10 Month 30 Day

Anticipated trial start date

2014 Year 12 Month 01 Day

Last follow-up date

2016 Year 03 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study evaluates radiation-induced skin symptoms and QOL quantitatively and qualitatively.


Management information

Registered date

2014 Year 11 Month 26 Day

Last modified on

2020 Year 06 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000017783


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name